CorMedix (CRMD) Gross Margin (2013 - 2026)
CorMedix (CRMD) reported Gross Margin of 75.66% for Q2 2026, down 19.65 percentage points from 95.31% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Gross Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CorMedix's Gross Margin came in at 84.20%, down 11.42 percentage points year-over-year; for FY2025, it was 88.46%, down 4.20 percentage points from FY2024.
- Gross Margin has a five-year change of +74.09 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 92.66% in FY2024, 94.29% in FY2022 (+72.30 pp) and 22.00% in FY2021 (+7.62 pp).
- The Q2 2026 figure ranks as the lowest quarterly Gross Margin since Q2 2024.
- Year over year, Gross Margin gained in 1 of the last four quarters, with an average year-over-year change of +5.34 percentage points.
- The high point for year-over-year Gross Margin in five years was Q2 2022 (a gain of 174.56 percentage points); the low point was Q2 2026 (a drop of 19.65 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | CorMedix | 417.07 Mn | -222.82 Mn | 77.13 Mn | 75.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.66% |
| Mar 31, 2026 | 82.50% |
| Dec 31, 2025 | 83.43% |
| Sep 30, 2025 | 89.26% |
| Jun 30, 2025 | 95.31% |
| Mar 31, 2025 | 95.91% |
| Dec 31, 2024 | 96.24% |
| Sep 30, 2024 | 94.01% |
| Jun 30, 2024 | 36.75% |
| Dec 31, 2022 | 98.63% |
| Sep 30, 2022 | 78.45% |
| Jun 30, 2022 | 98.44% |
| Mar 31, 2022 | 80.00% |
| Dec 31, 2021 | 14.88% |
| Sep 30, 2021 | 33.93% |
| Jun 30, 2021 | -76.12% |
| Mar 31, 2021 | 30.50% |
| Dec 31, 2020 | -2.72% |
| Sep 30, 2020 | 14.09% |
| Jun 30, 2020 | -16.67% |
API Access
CorMedix Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();